Russia claims a breakthrough in cancer treatment with a personalized mRNA vaccine, designed to train the immune system to ...

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

Shares of vaccine makers moved higher early Monday following a CDC report that the U.S. was seeing a significant uptick in ...

GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and ...

Alarming DNA Levels Found in Pfizer Vaccines** A shocking revelation has emerged from a peer-reviewed study conducted at an FDA laboratory, revealing signi ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Coronavirus Disease 2019 (COVID-19) + influenza vaccine is under clinical development by Pfizer and currently in Phase III for Unspecified Influenza Virus Infections.

Northern provinces in China have been hit with a surge of HMPV infections in the last three weeks. This has forced the centre ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

An University of Pennsylvania sign is seen in Philadelphia, Friday, Dec. 15, 2023. The University of Pennsylvania expects to ...

A proponent of the Great Barrington Declaration is comparing rejection of its "natural herd immunity" approach to the ...